The Estée Lauder Companies Earnings Call Transcripts
Fiscal Year 2026
-
Q2 delivered 4% organic sales growth, 43% EPS growth, and margin expansion, led by strong skincare, fragrance, and China performance. FY2026 outlook was raised, with top-end guidance targeted despite macro and travel retail headwinds.
-
Delivered 3% organic sales growth and 300 bps operating margin expansion in Q1, led by strong performance in China, fragrance, and online channels. Reaffirmed full-year guidance, with ongoing cost discipline, innovation, and strategic investments driving confidence despite macro volatility.
Fiscal Year 2025
-
Momentum is building across strategic pillars, with strong innovation, digital transformation, and new channel expansion driving market share gains in the U.S. and China. Organizational changes and a refreshed leadership team are enabling greater agility and confidence in sustained growth.
-
Progress across five strategic pillars is driving market share gains, especially in the U.S. and China, with innovation and digital expansion at the core. AI-driven efficiencies, portfolio evolution, and regional investments are supporting growth, while operational agility and margin improvement remain key priorities.
-
Fiscal 2025 saw an 8% organic sales decline, mainly from travel retail, but gross margin expanded and share gains were achieved in China, Japan, and the U.S. Fiscal 2026 guidance calls for flat to 3% organic sales growth, margin expansion, and continued cost savings, with risks from tariffs and market volatility.
-
Leadership outlined a five-pillar strategy focused on agility, innovation, and operational efficiency, leveraging AI and digital tools to drive growth and margin recovery. Channel expansion, brand portfolio optimization, and a diversified supply chain support balanced global growth amid industry volatility.
-
Organic net sales declined 9% year-over-year, with travel retail down 28% and non-travel retail down 3%, but gross margin expanded and EPS exceeded outlook. Market share gains in the U.S., China, and Japan were offset by ongoing macroeconomic and tariff risks.
-
Second quarter saw a 6% organic net sales decline and 20% drop in operating income, with gross margin expanding but operating margin contracting. The company is executing a major transformation via the 'Beauty Reimagined' strategy, expanding restructuring, and focusing on consumer-centric investments amid ongoing headwinds in Asia and travel retail.
-
Organic net sales declined 5% year-over-year, mainly due to weakness in China and Asia travel retail, but gross margin and EPS improved. The company withdrew its full-year outlook, cut its dividend, and announced leadership changes amid ongoing macro headwinds and restructuring.
Fiscal Year 2024
-
Prestige beauty continues to outpace mass market growth, but faces increased competition and evolving consumer behavior. Fiscal 2025 guidance reflects ongoing headwinds in China and travel retail, with margin expansion driven by the PRGP. The organization is shifting to empower local markets and invest in consumer-facing initiatives.
-
Fiscal 2024 saw a 2% organic sales decline, but Q4 returned to growth with an 8% increase. The outlook for 2025 remains cautious due to continued weakness in China and Asia Travel Retail, but margin expansion is expected through the PRGP and strategic pivots.
-
Margin recovery is driven by inventory management, innovation focus, and operational efficiency, targeting $1.1–$1.4 billion in net savings over two years. Growth is expected to accelerate, with strong performance in APAC and Europe, ongoing M&A, and a robust product pipeline fueling future expansion.